Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - TOTAL RECEIVABLES
Total Receivables OCUL - Ocular Therapeutix, Inc.
26.2 M
LAST VALUE
11.29%
2 YEAR CAGR
164.82%
5 YEAR CAGR
58.06%
10 YEAR CAGR